Strip1 antibodies are immunochemical tools designed to bind specifically to the Strip1 protein, which plays roles in cell survival, migration, and neural circuit development. Strip1 is conserved across species and interacts with STRIPAK components to regulate signaling pathways such as JNK/Jun-mediated apoptosis .
Retinal Ganglion Cell (RGC) Survival: Strip1 antibodies were used in zebrafish to demonstrate that loss of Strip1 triggers Jun-mediated apoptosis in RGCs, leading to disrupted inner plexiform layer (IPL) formation . Immunostaining confirmed Strip1 expression in RGCs and amacrine cells at 2 days post-fertilization (dpf) .
Cochlear Hair Cells: In mice, Strip1 antibodies revealed age-dependent expression in outer hair cells (OHCs) starting at postnatal day 14 (P14), with robust signals in both OHCs and inner hair cells (IHCs) by P21 .
Mesoderm Migration: Studies in Strip1-null mouse embryos showed disrupted mesoderm migration due to abnormal focal adhesions and actin cytoskeleton organization, validated using Strip1 antibodies in Western blot (WB) and immunofluorescence (IF) .
Cancer Metastasis: Strip1 knockdown in human cell lines reduced tumor growth by inducing cyclin-dependent kinase inhibitors, as confirmed via antibody-based assays .
Western Blot: Strip1 antibodies detect bands at ~95 kDa in zebrafish, mouse, and human lysates . For example, the Novus OTI7B8 antibody recognizes recombinant human Strip1 (NP_149079) with high specificity .
Immunofluorescence: In zebrafish retinas, Strip1 antibodies labeled RGCs and amacrine cells, while blocking peptides eliminated signals, confirming specificity .
Negative Controls: Commercial antibodies (e.g., Boster A09470) show no cross-reactivity with unrelated proteins in Sox2-positive cochlear support cells .
STRING: 7955.ENSDARP00000104433
UniGene: Dr.150345
Strip1 is a core component of the STRIPAK complex involved in multiple cellular processes including embryogenesis, development, circadian rhythms, and has been implicated in conditions such as type 2 diabetes and cancer progression. As a scaffolding protein, Strip1 mediates interactions between striatin family proteins and other components of the STRIPAK complex. In the auditory system, Strip1 plays important roles in hair cell development and maturation, while in the visual system, it regulates retinal ganglion cell survival by suppressing Jun-mediated apoptosis .
Strip1 shows developmentally regulated expression in various tissues. In the mouse cochlea, both mRNA and protein expression of Strip1 increases with age starting from postnatal day 3 (P3), reaching peak expression levels at P30. Immunofluorescence studies reveal that Strip1 protein becomes detectable in outer hair cells (OHCs) starting at P14, with expression in both inner hair cells (IHCs) and OHCs evident from P21 onward . In zebrafish, Strip1 mRNA is both maternally and zygotically expressed, becoming restricted to the eyes, optic tectum, and heart by 2 days post-fertilization (dpf), with specific expression in retinal ganglion cells (RGCs) and amacrine cells (ACs) .
For optimal immunofluorescent detection of Strip1 in tissue samples, researchers should consider the following methodology:
Sample preparation: For whole-mount staining, fix tissue samples in 4% paraformaldehyde. For sectioning, prepare cryosections of appropriate thickness (typically 10-20 μm).
Antibody selection: Use validated Strip1-specific antibodies. Research has successfully employed commercially available antibodies for both mouse and zebrafish Strip1 detection.
Co-staining markers: Include cell-type specific markers such as Myo7a for hair cells and Sox2 for supporting cells when working with cochlear samples . For retinal tissues, markers for specific cell types (e.g., RGCs, ACs) should be included.
Imaging considerations: Since Strip1 expression varies between cell types and developmental stages, z-stack imaging may be necessary to capture complete expression patterns, particularly when examining structures with complex 3D organization .
When using Strip1 antibody for immunodetection, several controls are essential:
Negative controls: Include samples without primary antibody to assess non-specific binding of secondary antibodies.
Genetic controls: When available, use Strip1 knockout or knockdown tissues as negative controls to confirm antibody specificity.
Developmental stage controls: Include samples from multiple developmental stages, as Strip1 expression changes during development (e.g., P3 cochlear samples show minimal Strip1 expression and can serve as comparative controls) .
Cross-reactivity controls: Verify that the Strip1 antibody does not cross-react with other STRIPAK complex proteins, particularly Strip2, which is also expressed in some of the same cell types .
Homozygous Strip1 knockout (Strip1-/-) is embryonic lethal, presenting a significant challenge for studying Strip1 function in mature tissues. Studies have shown that when crossing Strip1 heterozygous knockout (Strip1+/-) mice, no homozygous knockouts were obtained, with the ratio of Strip1+/- to Strip1+/+ mice being approximately 2:1, confirming embryonic lethality . Researchers can address this challenge through:
Conditional knockout approaches: Generate Strip1-floxp mice and cross them with cell-type specific Cre lines (e.g., Atoh1-Cre for hair cell-specific deletion) .
Temporal control systems: Employ inducible Cre systems to delete Strip1 at specific developmental timepoints, avoiding early embryonic lethality.
Heterozygous models: Study Strip1+/- animals, although these may have normal phenotypes as observed in hearing function studies .
Alternative models: Use zebrafish or other model organisms where tissue-specific CRISPR-Cas9 approaches can be employed for temporal and spatial control of gene editing .
To identify Strip1-interacting proteins, researchers have successfully employed:
Co-immunoprecipitation coupled with mass spectrometry (Co-IP/MS): This approach has identified six proteins enriched only by wild-type Strip1, five of which are components of the STRIPAK complex .
Control considerations: Use multiple controls including:
Validation approaches: Confirm interactions through:
Strip1 plays a critical role in promoting neuronal cell survival, particularly in retinal ganglion cells (RGCs). Research indicates that:
Mechanism of action: Strip1, likely through the STRIPAK complex, suppresses Jun-mediated proapoptotic signaling in RGCs during development .
Experimental evidence:
Pathway analysis: Strip1 deficiency leads to upregulation of Jun protein, and pharmacological inhibition of Jun N-terminal kinase (JNK) significantly reduces apoptosis in Strip1 mutants .
Interacting partners: Knockdown of Strn3, a Strip1-interacting partner identified through Co-IP/MS, results in similar RGC apoptosis, suggesting a functional complex between these proteins in regulating cell survival .
Distinguishing the specific functions of Strip1 from other striatin-interacting proteins requires careful experimental design:
Expression pattern analysis: Strip1 shows specific expression patterns that may differ from other family members. For example, Striatin (STRN) is specifically expressed in cell-cell junctions of inner hair cells, whereas Strip1 is expressed in both inner and outer hair cells .
Genetic approaches:
Generate specific knockouts/knockdowns for each family member
Create double or triple knockouts to identify redundant or unique functions
Use rescue experiments with individual family members in knockout backgrounds
Domain analysis: Create chimeric proteins or domain deletions to identify which regions of Strip1 mediate specific functions or interactions.
Cross-species comparison: Analyze conservation of function across model organisms, as some functions may be species-specific while others are universal .
For accurate quantification of Strip1 expression:
mRNA expression:
Protein expression:
Western blotting with appropriate normalization to housekeeping proteins
Quantitative immunofluorescence using standardized imaging parameters and analyzing fluorescence intensity
Developmental analysis:
Data analysis considerations:
Use appropriate statistical tests for comparing expression levels
Consider biological replicates from multiple animals to account for individual variation
For immunofluorescence quantification, analyze multiple sections/regions per sample
When designing genetic manipulation experiments for Strip1, researchers should consider:
Complete knockout considerations:
Conditional knockout strategies:
Knockdown approaches:
Validation of genetic manipulation:
Confirmation of reduced Strip1 levels using qPCR, western blotting, and immunofluorescence
Inclusion of rescue experiments to confirm specificity of observed phenotypes
Non-specific binding is a common challenge with antibodies. For Strip1 antibodies:
Validation approaches:
Use genetic models (knockouts/knockdowns) as negative controls
Perform peptide competition assays to confirm specificity
Test multiple antibodies targeting different epitopes
Optimization strategies:
Titrate antibody concentrations to minimize background
Modify blocking conditions (duration, composition of blocking solution)
Adjust washing steps (number, duration, detergent concentration)
Sample-specific considerations:
When interpreting phenotypes in Strip1 knockout/knockdown models, consider:
Primary vs. secondary effects:
Compensatory mechanisms:
Developmental timing:
Strip1 expression changes throughout development, so phenotypes may differ depending on when function is disrupted
Early effects may cascade to cause secondary phenotypes later in development
Tissue interactions:
Strip1 functions within the larger context of STRIPAK complex signaling:
STRIPAK components:
Integration with apoptotic pathways:
Developmental regulation:
Research approaches:
Systems biology approaches (protein interaction networks, pathway analysis)
Comparative studies across different cell types and organisms
Integration of genetic, biochemical, and cell biological data
Future Strip1 research may benefit from:
Advanced imaging techniques:
Super-resolution microscopy to resolve subcellular localization
Live-cell imaging with tagged Strip1 to track dynamics
Expansion microscopy for improved spatial resolution in complex tissues
Proximity labeling approaches:
BioID or APEX2 fusions to identify proximity partners in living cells
More comprehensive identification of the Strip1 interactome in different cell types
Single-cell technologies:
Single-cell proteomics to complement existing RNA-seq data
Spatial transcriptomics to map Strip1 expression in intact tissues
CRISPR technologies:
Base editing or prime editing for more precise genetic manipulation
CRISPR activation/inhibition systems to modulate Strip1 expression without genetic deletion
When facing contradictory data about Strip1 across different models:
Species-specific differences:
Compare Strip1 sequences across species to identify conserved vs. divergent domains
Consider evolutionary adaptations that might alter Strip1 function
Context-dependent functions:
Strip1 may interact with different partners in different cell types
Expression levels of interacting proteins may vary across tissues
Methodological considerations:
Different knockout strategies may result in different phenotypes
Antibody specificity may vary across species or applications
Integrative approaches:
Use complementary methods to address the same question
Consider genetic interaction studies to map functional relationships
Employ rescue experiments with constructs from different species